Triazolam and Topamax drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Triazolam (triazolam) and Topamax (topiramate). Common drug interactions include rhinorrhoea among females and asthma among males.

The phase IV clinical study analyzes what interactions people have when they take Triazolam and Topamax. It is created by eHealthMe based on reports of 51 people who take the same drugs from the FDA, and is updated regularly.

What is Triazolam?

Triazolam has active ingredients of triazolam. It is often used in insomnia. eHealthMe is studying from 5,838 Triazolam users. Check the latest studies of Triazolam.

What is Topamax?

Topamax has active ingredients of topiramate. It is often used in migraine. eHealthMe is studying from 58,954 Topamax users. Check the latest studies of Topamax.



On Jul, 26, 2026

51 people who take Triazolam and Topamax together, and have interactions are studied.

Triazolam and Topamax drug interactions.

What are the common drug interactions of Triazolam and Topamax, by gender? *:

female:

  1. Rhinorrhoea (watery mucus discharge from the nose)
  2. Sepsis (a severe blood infection that can lead to organ failure and death)
  3. Dyspnoea (difficult or laboured respiration)
  4. Nausea (feeling of having an urge to vomit)
  5. Pneumonia
  6. Abdominal pain
  7. Coma (state of unconsciousness lasting more than six hours)
  8. Cutaneous vasculitis (an inflammatory process affecting the vessel wall that leads to its damage)
  9. Hypotension (abnormally low blood pressure)
  10. Pain

male:

  1. Asthma
  2. Drug toxicity
  3. Therapeutic response unexpected
  4. Tongue eruption (an appearance of rash on tongue)
  5. Cardiac disorder
  6. Drug administration error
  7. Drug ineffective
  8. Glossitis (infection of tongue with soreness)
  9. Glossodynia (a burning or painful sensation in the tongue)
  10. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)

What are the common drug interactions of Triazolam and Topamax, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Coma (state of unconsciousness lasting more than six hours)
  2. Hypotension (abnormally low blood pressure)
  3. Drug abuse
  4. Intentional self-injury
  5. Overdose

40-49:

  1. Asthma
  2. Drug toxicity
  3. Cardiac disorder
  4. Chronic kidney disease
  5. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)

50-59:

  1. Blood pressure decreased
  2. Confusional state
  3. Gastric bypass
  4. Hallucination (an experience involving the perception of something not present)
  5. Head injury
  6. Headache (pain in head)
  7. Loss of consciousness
  8. Memory impairment
  9. Muscle spasms (muscle contraction)
  10. Pain

60+:

  1. Feeling cold
  2. Aphasia (damage to the parts of the brain that control language)
  3. Hypersensitivity
  4. Influenza like illness
  5. Malaise (a feeling of general discomfort or uneasiness)
  6. Mental impairment (a condition affecting the body, perhaps through sight or hearing loss, a mobility difficulty or a health condition)
  7. Metastases to retroperitoneum (cancer spreads to retroperitonium)
  8. Nasopharyngitis (inflammation of the nasopharynx)
  9. Nausea (feeling of having an urge to vomit)
  10. Pain

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 9 people, 17.65%
  2. Immunodeficiency Common Variable: 8 people, 15.69%
  3. Stress And Anxiety: 5 people, 9.80%
  4. Hypersensitivity: 4 people, 7.84%
  5. Restless Leg Syndrome (a powerful urge to move your legs): 4 people, 7.84%
  6. Fibromyalgia (a long-term condition which causes pain all over the body): 4 people, 7.84%
  7. Tremor (trembling or shaking movements in one or more parts of your body): 3 people, 5.88%
  8. Drowsiness: 3 people, 5.88%
  9. Fat Intolerance (inability to use fat by digestive system): 3 people, 5.88%
  10. Hiatal Hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm): 3 people, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Triazolam and Topamax?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Triazolam and Topamax:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Triazolam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Topamax:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Triazolam and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Topamax and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on triazolam and topiramate (the active ingredients of Triazolam and Topamax, respectively), and Triazolam and Topamax (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: